Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Heme polymerization in Plasmodium species, particularly *Plasmodium falciparum*, is a critical biological process that allows the malaria parasite to survive within red blood cells. During its intraerythrocytic stage, the parasite digests host hemoglobin to obtain amino acids for growth. This digestion releases free heme (ferriprotoporphyrin IX), which is highly toxic due to its ability to generate reactive oxygen species and disrupt cellular membranes. To avoid toxicity, Plasmodium rapidly detoxifies free heme by converting it into an insoluble crystalline pigment called hemozoin (also known as β-hematin).
Inhibition of hemozoin formation, leading to accumulation of toxic free heme.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heme Polymerization (Plasmodium) (N/A).